Shilpa medicare gets CDSCO approval for Tranexamic Acid Spray, Hemostatic Spray. The product is protected by granted patents in India till 2037 and in US, Australia, Russia and South Africa till 2038. Shilpa is continuously pursuing patent prosecution in other countries and for further protection.
- Read more about Shilpa medicare bags CDSCO approval for Tranexamic Acid Spray
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/shilpa-medicare-bags-cdsco-approval-for-tranexamic-acid-spray
No comments:
Post a Comment